nach oben

Somnologie

Erschienen in:

28.01.2019 | Reviews

Obstructive sleep apnea and atherosclerosis—update 2019

verfasst von: Dr. med. Leonie Biener, Carmen Pizarro, Georg Nickenig, Dirk Skowasch

Erschienen in: Somnologie | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Obstructive sleep apnea (OSA) is a common disorder that has been associated with an increased risk of atherosclerosis and its clinical manifestations. While treatment with continuous positive airway pressure (CPAP) has been shown to exert several beneficial effects on cardiovascular disease and prognosis in observational studies, CPAP was not effective in three recent randomized controlled trials unless it was used for more than 4 hours of sleep.

WHO (2018) Global health estimates 2016: deaths by cause, age, sex, by country and by region, 2000–2016. World Health Organization, Geneva

WHO (2017) WHO Fact sheet N°317. www.who.int/mediacentre/factsheets/fs317/en/ (Created 05.2017). Accessed 29 Oct 2018

Riemann D, Baum E, Cohrs S et al (2017) S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 21(2). https://doi.org/10.1007/s11818-016-0097-x CrossRef

Skowasch D, Bönner G, Nickenig G (2009) Obstruktive Schlafapnoe als Risikofktor der Arteriosklerose

Maeder MT, Schoch OD, Rickli H (2016) A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease. Vasc Health Risk Manag 12:85–103. https://doi.org/10.2147/VHRM.S74703 CrossRef

Tuleta I, Pabst S, Juergens UR, Nickenig G, Skowasch D (2011) Obstructive sleep apnoea as a risk factor for atherosclerosis—implication for preventive and personalised treatment. Epma J 2:39–47. https://doi.org/10.1007/s13167-011-0070-5 CrossRef

Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. Circulation 118:1080–1111. https://doi.org/10.1161/CIRCULATIONAHA.107.189375 (In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health))CrossRef

Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19:2271–2277CrossRef

Pearse SG, Cowie MR (2016) Sleep-disordered breathing in heart failure. Eur J Heart Fail 18:353–361. https://doi.org/10.1002/ejhf.492 CrossRef

10.

Mbata G, Chukwuka J (2012) Obstructive sleep apnea hypopnea syndrome. Ann Med Health Sci Res 2:74–77. https://doi.org/10.4103/2141-9248.96943 CrossRef

11.

Oldenburg O, Arzt M, Bitter T et al (2015) Positionspapier „Schlafmedizin in der Kardiologie“. Kardiologe 9(140). https://doi.org/10.1007/s12181-015-0654-8 CrossRef

12.

Eckert DJ, Younes MK (2014) Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment. J Appl Physiol (1985) 116:302–313. https://doi.org/10.1152/japplphysiol.00649.2013 CrossRef

13.

Quan SF (2012) Obstructive sleep apnea and cardiovascular disease: back and forward in time over the last 25 years. Southwest J Pulm Crit Care 5:206–217

14.

Drager LF, McEvoy RD, Barbe F, Lorenzi-Filho G, Redline S, INCOSACT Initiative (International Collaboration of Sleep Apnea Cardiovascular Trialists) (2017) Sleep apnea and cardiovascular disease: lessons from recent trials and need for team science. Circulation 136:1840–1850. https://doi.org/10.1161/CIRCULATIONAHA.117.029400 CrossRef

15.

Song D, Fang G, Greenberg H, Liu SF (2015) Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review. Immunol Res 63:121–130. https://doi.org/10.1007/s12026-015-8703-8 CrossRef

16.

Adedayo AM, Olafiranye O, Smith D, Hill A, Zizi F, Brown C et al (2014) Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath Schlaf Atm 18:13–18. https://doi.org/10.1007/s11325-012-0760-9 CrossRef

17.

Eisele H‑J, Markart P, Schulz R (2015) Obstructive sleep apnea, oxidative stress, and cardiovascular disease: evidence from human studies. Oxid Med Cell Longev 2015:608438. https://doi.org/10.1155/2015/608438 CrossRef

18.

Xing T, Pilowsky PM (2010) Acute intermittent hypoxia in rat in vivo elicits a robust increase in tonic sympathetic nerve activity that is independent of respiratory drive. J Physiol 588:3075–3088. https://doi.org/10.1113/jphysiol.2010.190454 CrossRef

19.

Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484. https://doi.org/10.1183/09031936.00086608 CrossRef

20.

Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ et al (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25. https://doi.org/10.1164/ajrccm.163.1.2001008 CrossRef

21.

Lalande S, Luoma CE, Miller AD, Johnson BD (2012) Effect of changes in intrathoracic pressure on cardiac function at rest and during moderate exercise in health and heart failure. Exp Physiol 97:248–256. https://doi.org/10.1113/expphysiol.2011.061945 CrossRef

22.

Linz D, Mahfoud F, Linz B, Hohl M, Schirmer SH, Wirth KJ et al (2014) Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea. Am J Hypertens 27:1293–1300. https://doi.org/10.1093/ajh/hpu036 CrossRef

23.

Amatoury J, Howitt L, Wheatley JR, Avolio AP, Amis TC (2006) Snoring-related energy transmission to the carotid artery in rabbits. J Appl Physiol Bethesda Md 1985 100:1547–1553. https://doi.org/10.1152/japplphysiol.01439.2005 CrossRef

24.

Lui MM-S, Sau-Man M (2012) OSA and atherosclerosis. J Thorac Dis 4:164–172. https://doi.org/10.3978/j.issn.2072-1439.2012.01.06 CrossRef

25.

Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904. https://doi.org/10.1172/JCI118235 CrossRef

26.

Castaneda A, Jauregui-Maldonado E, Ratnani I, Varon J, Surani S (2018) Correlation between metabolic syndrome and sleep apnea. World J Diabetes 9:66–71. https://doi.org/10.4239/wjd.v9.i4.66 CrossRef

27.

Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A et al (2012) Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307:2161–2168. https://doi.org/10.1001/jama.2012.4366 CrossRef

28.

Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A et al (2007) The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167:757–764. https://doi.org/10.1001/archinte.167.8.757 CrossRef

29.

Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet Lond Engl 365:1046–1053. https://doi.org/10.1016/S0140-6736(05)71141-7 CrossRef

30.

Spießhöfer J, Fox H, Lehmann R, Efken C, Heinrich J, Bitter T et al (2016) Heterogenous haemodynamic effects of adaptive servoventilation therapy in sleeping patients with heart failure and Cheyne-Stokes respiration compared to healthy volunteers. Heart Vessels 31:1117–1130. https://doi.org/10.1007/s00380-015-0717-6 CrossRef

31.

Oldenburg O, Bartsch S, Bitter T, Schmalgemeier H, Fischbach T, Westerheide N et al (2012) Hypotensive effects of positive airway pressure ventilation in heart failure patients with sleep-disordered breathing. Sleep Breath Schlaf Atm 16:753–757. https://doi.org/10.1007/s11325-011-0571-4 CrossRef

32.

Amin M (2016) Can continuous positive airway pressure reverse carotid artery atherosclerosis in obstructive sleep apnea? Egypt J Chest Dis Tuberc 65:765–769CrossRef

33.

Chen L‑D, Lin L, Lin X‑J, Ou Y‑W, Wu Z, Ye Y‑M et al (2017) Effect of continuous positive airway pressure on carotid intima-media thickness in patients with obstructive sleep apnea: a meta-analysis. PLoS ONE 12:e184293. https://doi.org/10.1371/journal.pone.0184293 CrossRef

34.

Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68–73CrossRef

35.

Robinson GV, Langford BA, Smith DM, Stradling JR (2008) Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA). Thorax 63:855–859. https://doi.org/10.1136/thx.2007.088096 CrossRef

36.

McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X et al (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375:919–931. https://doi.org/10.1056/NEJMoa1606599 CrossRef

37.

Iftikhar IH, Valentine CW, Bittencourt LRA, Cohen DL, Fedson AC, Gíslason T et al (2014) Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens 32:2341–2350. https://doi.org/10.1097/HJH.0000000000000372 (discussion 2350)CrossRef

38.

Torres G, Sánchez-de-la-Torre M, Barbé F (2015) Relationship between OSA and hypertension. Chest 148:824–832. https://doi.org/10.1378/chest.15-0136 CrossRef

39.

Feldstein CA (2016) Blood pressure effects of CPAP in nonresistant and resistant hypertension associated with OSA: a systematic review of randomized clinical trials. Clin Exp Hypertens N Y N 1993 38:337–346. https://doi.org/10.3109/10641963.2016.1148156 CrossRef

40.

Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM (2012) Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 156:115–122. https://doi.org/10.7326/0003-4819-156-2-201201170-00006 CrossRef

41.

Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A (2007) Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol 50:1310–1314. https://doi.org/10.1016/j.jacc.2007.06.028 CrossRef

42.

Doherty LS, Kiely JL, Swan V, McNicholas WT (2005) Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127:2076–2084. https://doi.org/10.1378/chest.127.6.2076 CrossRef

43.

Milleron O, Pillière R, Foucher A, de Roquefeuil F, Aegerter P, Jondeau G et al (2004) Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25:728–734. https://doi.org/10.1016/j.ehj.2004.02.008 CrossRef

44.

Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunström E (2016) Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with Nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial. Am J Respir Crit Care Med 194:613–620. https://doi.org/10.1164/rccm.201601-0088OC CrossRef

45.

Yu J, Zhou Z, McEvoy RD, Anderson CS, Rodgers A, Perkovic V et al (2017) Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. JAMA 318:156–166. https://doi.org/10.1001/jama.2017.7967 CrossRef

46.

Esquinas C, Sánchez-de-la Torre M, Aldomá A, Florés M, Martínez M, Barceló A et al (2013) Rationale and methodology of the impact of continuous positive airway pressure on patients with ACS and nonsleepy OSA: the ISAACC Trial. Clin Cardiol 36:495–501. https://doi.org/10.1002/clc.22166 CrossRef

Titel: Obstructive sleep apnea and atherosclerosis—update 2019
verfasst von: Dr. med. Leonie Biener
Carmen Pizarro
Georg Nickenig
Dirk Skowasch
Publikationsdatum: 28.01.2019
Verlag: Springer Medizin
Erschienen in: Somnologie / Ausgabe 1/2019
Print ISSN: 1432-9123
Elektronische ISSN: 1439-054X
DOI: https://doi.org/10.1007/s11818-019-0194-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Obstructive sleep apnea and atherosclerosis—update 2019

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

CME: Ursache und Therapie von Albträumen

Assessment of ability to drive in obstructive sleep apnea patients using a driving simulator

Vaskuläre Konsequenzen schlafbezogener Erkrankungen

Sleep state misperception in psychiatric patients

Is there a causal relationship between obstructive sleep apnea and the pathophysiology of intracranial aneurysm?

Resolution of ST deviation after myocardial infarction in patients with and without sleep-disordered breathing

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie